Peter Gee, Huaigeng Xu, & Akitsu Hotta. (2017). Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy. Hindawi Limited.
Chicago Style (17th ed.) CitationPeter Gee, Huaigeng Xu, and Akitsu Hotta. Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy. Hindawi Limited, 2017.
MLA (9th ed.) CitationPeter Gee, et al. Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy. Hindawi Limited, 2017.
Warning: These citations may not always be 100% accurate.